For the Quarter Ending June 2025
Asia Pacific (APAC)
• Why did the price change in July 2025? The Price Index for Monosulfiram in Asia dipped further in early July 2025 as distributors remained cautious due to existing inventory surpluses.
• In India June’s Monosulfiram Spot Price stood at USD 15,989.51 per metric ton and reflected a 0.72% decline.
• The Monosulfiram Spot Price in Asia had earlier increased in April and May 2025 that was driven by seasonal demand from pharmaceuticals and personal care segments. The prices began to decline in June due to demand fatigue and surplus stock conditions.
• The Monosulfiram Price Forecast turned bearish in June as buyers abstained from fresh procurement amidst tepid downstream off-take, compounded by monsoon-related lifestyle shifts that curtailed product usage.
• Throughout Q2, the Monosulfiram Production Cost Trend remained largely stable, as feedstock availability and operating rates at Indian manufacturing units continued uninterrupted.
• Despite initial bullish procurement behaviour in April, June saw visible demand weakening from key sectors like derma, personal hygiene, and animal care, softening the Monosulfiram Demand Outlook.
• Strategic stockpiling in April and May led to bloated inventories by June, which discouraged replenishment and pressured market sentiment downward.
• Efficient inland distribution persisted across India, even during monsoon progression, preventing any supply-side disruption or logistics-induced price volatility.
• Domestic manufacturers maintained regular production schedules, with supply discipline observed in May contributing to temporary price firmness.
• With Q2 ending on a subdued note, July opened with restrained spot purchases, as importers and end-users monitored inventory drawdowns and market corrections.
North America
• Why did the price change in July 2025? The Monosulfiram Price Index in North America showed signs of softening in early July 2025 as consumer healthcare and veterinary distributors scaled back fresh procurement amid adequate inventories and moderate summer demand.
• The Monosulfiram Spot Price in April and May saw gradual firming as procurement accelerated for summer healthcare formulations, particularly for veterinary skin care and antifungal topical products.
• By June, downstream demand signals began to decelerate slightly, triggering conservative inventory planning, which reflected in a flat-to-weak Monosulfiram Price Forecast.
• Stable production and secure feedstock access kept the Monosulfiram Production Cost Trend neutral throughout the quarter in North America.
• Demand from dermatology and hygiene segments remained moderate, influenced by a less severe fungal outbreak season and greater consumer inventory optimization.
• No major import reliance or supply delays were reported; domestic formulators maintained scheduled procurement tied to monthly usage rates.
• Distributors reported higher-than-average stock availability in June, having procured aggressively during the early Q2 price incline phase.
• North American formulators strategically spaced out their purchase cycles post-May, leading to subdued market movement in June.
• The Q2 cycle concluded with a relatively balanced market, with early-quarter strength offset by end-quarter caution, ahead of a modest July slowdown in Monosulfiram Demand Outlook.
Europe
• Why did the price change in July 2025? In Europe, the Price Index for Monosulfiram declined marginally in July 2025 due to sluggish consumption recovery and cautious stockholding following weak Q2 off-take in dermatological and veterinary product lines.
• The Monosulfiram Spot Price in Europe showed modest strength in April amid early seasonal demand, particularly from personal care manufacturers anticipating summer skincare product launches.
• May registered stable procurement from pharmaceutical manufacturers, but lacked significant momentum, with Monosulfiram Price Forecast signals remaining neutral.
• By June, demand contraction set in as downstream buyers, facing unexciting consumer movement, deferred procurement — a trend echoed in the broader Monosulfiram Demand Outlook.
• European buyers prioritized lean inventory models, especially in Western Europe, to avoid surplus accumulation observed during Q1 and early Q2.
• The Monosulfiram Production Cost Trend remained stable in Europe, with no supply-side inflation reported. Local manufacturing operated on demand-based planning.
• Regional distribution logistics functioned efficiently throughout Q2, with no external disruptions affecting availability or delivery cycles.
• Export-reliant buyers in Eastern Europe showed weaker activity in May and June due to soft purchasing cues from Middle East and African clients.
• Q2 closed with European Monosulfiram markets entering July cautiously, maintaining only operational inventories and trimming future spot purchases.
For the Quarter Ending March 2025
North America
The Monosulfiram market in North America experienced a stable and consistent phase during the first quarter of 2025. Market conditions remained steady throughout the period with prices holding firm and trading activity being well-managed across the region. During this quarter, certain tariff adjustments were introduced and affected various pharmaceutical ingredients based on their product type and category. However, the overall impact on Monosulfiram remained controlled with suppliers and buyers adjusting procurement strategies accordingly.
Many buyers focused on maintaining balanced inventory levels and preferred to avoid bulk purchases in anticipation of any possible market shifts. Demand from downstream pharmaceutical sectors in dermatology and anti-parasitic applications, continued at a moderate and predictable pace. Seasonal transition from winter to early spring brought no sharp demand spikes and allowed suppliers to manage supply chains smoothly without major disruptions.
The steady availability of cargo space and reliable logistics routes further supported market stability. As a result, Monosulfiram prices moved within a tight range and both buyers and suppliers kept a close watch on tariff policies and upcoming production cycles likely to shape the upcoming period activity.
Asia Pacific
The Monosulfiram market in Asia Pacific showed a quarterly price drop of 7.46% in first quarter of 2025. This decline was mainly driven by weak demand and well-managed inventories across the region. Pharmaceutical companies across key Asia Pacific markets displayed cautious procurement behaviour during this period. Festive holidays in major exporting countries led to temporary production slowdowns and delayed purchasing activity, which played a part in keeping prices stable across the region.
Seasonal transitions from winter to early spring also meant demand for certain dermatology medicines softened, lowering procurement volumes. Suppliers strategically adjusted prices to attract steady orders without allowing excess stock to build up. Buyers planned their purchases carefully and avoided any unnecessary inventory pileups. The region’s exporters also faced competitive market conditions, where steady pricing became essential to maintain trade flows.
Overall, the price correction reflected a cautious market with controlled demand and balanced supply. As production activities gradually picked up towards the end of March several suppliers began adjusting price offers for the upcoming quarter in response to anticipated healthcare needs.
Europe
The Monosulfiram market in Europe maintained steady pricing throughout the first quarter of 2025. Market activity stayed within a consistent and predictable range, supported by stable demand from the pharmaceutical sector. Requirements for dermatological treatments and anti-parasitic medicines which is one of the primary uses for pharmaceutical-grade Monosulfiram in this region, continued at a regular pace and contributed to balanced market conditions.
Buyers showed a careful and planned procurement strategy throughout the quarter. Many companies focused on purchasing in smaller and routine volumes to ensure their inventory levels were balanced without risking overstock. This cautious buying behaviour was mainly due to moderate demand and the absence of any major seasonal spikes in medical requirements during the winter to early spring months.
Suppliers maintained a stable supply chain which was supported by smooth logistics and reliable product availability. The absence of any significant supply disruptions allowed the market to avoid sharp price fluctuations. Minor adjustments in offers were occasionally observed on a transactional basis. Both suppliers and buyers remained attentive to international pricing signals during the production and procurement cycles in the first quarter of 2025.
FAQs
Q1. What is Monosulfiram and what are its common applications?
Monosulfiram is a topical antiparasitic and antifungal compound widely used in dermatological preparations. It is commonly applied in the treatment of scabies, pediculosis (lice infestation), and other skin conditions. It is also utilized in veterinary formulations for ectoparasite control and in personal care products such as antifungal soaps, shampoos, and creams.
Q2. Which sectors primarily drive the demand for Monosulfiram?
The main demand for Monosulfiram comes from the pharmaceutical, personal care, and veterinary healthcare sectors. Pharmaceutical manufacturers use it in topical formulations, while personal care brands incorporate it in hygiene and antifungal products. Veterinary use is focused on animal skin treatments and pest control.
Q3. Is Monosulfiram a domestically produced product or import-dependent?
In several key manufacturing countries like India, Monosulfiram is primarily domestically produced with stable internal supply chains. These markets are largely self-sufficient, and production is managed locally with limited reliance on imports, although select exporters serve smaller or formulation-dependent markets abroad.
Q4. What seasonal or cyclical factors affect Monosulfiram demand?
Demand for Monosulfiram typically rises in warmer months when fungal skin infections and parasitic conditions are more prevalent. However, prolonged monsoons or high humidity can also trigger demand shifts. In some regions, veterinary and hygiene product cycles further influence procurement patterns.
Q5. What influences Monosulfiram price trends in global markets?
Price movements are largely influenced by downstream demand trends, inventory behaviour, and production discipline at manufacturing units. Factors such as overstocking, subdued seasonal demand, or guarded supplier inventory strategies can significantly affect the Monosulfiram Price Index in different regions.
